Genomic & Biopharma News

Aurobindo takes top generic spot in Portugal with €135M deal for Generis
Aurobindo takes top generic spot in Portugal with €135M deal for Generis epalmer Mon, 01/09/2017 - 12:01
Fierce Pharma, 2017-01-09 17:01:06

Mediterranean plants may become source for 'elixir of life'
The Mediterranean is a haven for lovers of crystal-clear seas and sun-kissed landscapes. Now, thanks to the work of scientists from the University of Malta and the Centre National de la Recherche Scientifique, it has the added appeal of being an actual fountain of youth.
News Medical Life Sciences, 2017-01-09 17:00:25

Study finds new link between short sleep during pregnancy and gestational diabetes mellitus
A Singapore-based study has found a new health link between short sleep during pregnancy and gestational diabetes mellitus (GDM).
News Medical Life Sciences, 2017-01-09 16:48:13

Hospitals reduce bloodstream infections and healthcare costs with catheter safeguards, study shows
U.S. hospitals are reducing bloodstream infections related to catheters by implementing rigorous safeguards that also save millions of healthcare dollars each year, according to research led by Cedars-Sinai.
News Medical Life Sciences, 2017-01-09 16:45:05

Takeda shells out whopping $5.2B for Ariad, Iclusig and its fledgling med brigatinib
Takeda shells out whopping $5.2B for Ariad, Iclusig and its fledgling med brigatinib tracy Mon, 01/09/2017 - 11:34
Fierce Pharma, 2017-01-09 16:34:39

Researchers discover new natural tooth repair method using Alzheimer's drug
A new method of stimulating the renewal of living stem cells in tooth pulp using an Alzheimer's drug has been discovered by a team of researchers at King's College London.
News Medical Life Sciences, 2017-01-09 16:33:36

Mothers' use of acid-suppressing medication during pregnancy may be linked to asthma in children
Children born to mothers who take heartburn medication during pregnancy may have a greater risk of developing asthma, research suggests.
News Medical Life Sciences, 2017-01-09 16:24:49

EpiPen set to lose $800M in sales by 2018, thanks to new rivals, authorized generic: analyst
EpiPen set to lose $800M in sales by 2018, thanks to new rivals, authorized generic: analyst esagonowsky Mon, 01/09/2017 - 11:23
Fierce Pharma, 2017-01-09 16:23:51

Evotec now more than a partner to Eternygen, but an investor
Evotec now more than a partner to Eternygen, but an investor aliu Mon, 01/09/2017 - 11:00
Fierce Biotech, 2017-01-09 16:00:17